125 related articles for article (PubMed ID: 14995078)
1. Evaluation of metallothionein and p53 expression as potential prognostic markers for laryngeal squamous cell carcinoma.
Brown JJ; Xu H; William-Smith L; Mohamed H; Teklehaimanot S; Zhuo J; Osborne R; Liu F; Gowans RE; Nishitani J; Liu X
Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL473-9. PubMed ID: 14995078
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
4. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
[TBL] [Abstract][Full Text] [Related]
5. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between expression of p53 and prognosis of laryngeal squamous carcinoma].
Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Zhang Q
Ai Zheng; 2003 Jan; 22(1):77-82. PubMed ID: 12561442
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
9. Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma.
Cardoso SV; Silveira-Júnior JB; De Carvalho Machado V; De-Paula AM; Loyola AM; De Aguiar MC
Anticancer Res; 2009 Apr; 29(4):1189-93. PubMed ID: 19414363
[TBL] [Abstract][Full Text] [Related]
10. Possible prognostic role of p53 expression in laryngeal squamous cell carcinoma of non-smokers, non-alcoholic patients.
Fernandez-Acenero MJ; Larach F; Aramendi T; Ortega P
Acta Otolaryngol; 2008; 128(12):1385-8. PubMed ID: 18607961
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis.
Shigyo H; Nonaka S; Katada A; Bandoh N; Ogino T; Katayama A; Takahara M; Hayashi T; Harabuchi Y
Acta Otolaryngol; 2007 Sep; 127(9):970-9. PubMed ID: 17712678
[TBL] [Abstract][Full Text] [Related]
12. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
[TBL] [Abstract][Full Text] [Related]
14. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer.
Pastuszewski W; Dziegiel P; Krecicki T; Podhorska-Okolow M; Ciesielska U; Gorzynska E; Zabel M
Anticancer Res; 2007; 27(1A):335-42. PubMed ID: 17352251
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
[TBL] [Abstract][Full Text] [Related]
17. p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma.
Allegra E; Puzzo L; Cutrona D; Trichini A; Garozzo A; Serra A
Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):454-8. PubMed ID: 15198048
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus.
Hishikawa Y; Koji T; Dhar DK; Kinugasa S; Yamaguchi M; Nagasue N
Br J Cancer; 1999 Oct; 81(4):712-20. PubMed ID: 10574261
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
Pizem J; Cör A; Gale N
Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]